FDA Brief

Company record

Wisconsin Pharmacal Company, LLC

1 FDA warning letter since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Wisconsin Pharmacal Company, LLC.

Warning letters

  1. Wisconsin Pharmacal Company, LLC

    FDA warns Wisconsin Pharmacal over OTC drug manufacturing violations, including released rejected product and S. aureus contamination.

    High risk

Recalls

ReportedClassFirmProduct and reason
May 27 Class I Wisconsin Pharmacal Company
Drug
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.